Bristol Myers Squibb Stock Climbs on Alzheimer's Trial Update. What to Know.
Bristol-Myers SquibbBristol-Myers Squibb(US:BMY) Barrons·2025-12-03 14:16

Group 1 - The company is testing its antipsychotic drug Cobenfy for the treatment of psychosis associated with Alzheimer's disease [1]